Amarin Corp. (AMRN) Misses Q2 EPS by 3c

Amarin Corp. (NASDAQ: AMRN) reported Q2 EPS of ($0.09), $0.03 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $90.6 million versus the consensus estimate of $87.62 million.

For earnings history and earnings-related data on Amarin Corp. (AMRN) click here.

You May Also Be Interested In

• Nebius soars on second quarter revenue beat
• Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
• Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS